Page 2 - பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் Today - Breaking & Trending Today

Nearly half of all women are denied their bodily autonomy, says new UNFPA report, My Body is My Own

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Nearly half of all women are denied their bodily autonomy, says new UNFPA report, My Body is My Own
UNFPAApril 14, 2021 GMT
New York, April 14, 2021 (GLOBE NEWSWIRE) Nearly half of women in 57 developing countries are denied the right to decide whether to have sex with their partners, use contraception or seek health care, according to UNFPA’s 2021 flagship State of World Population report, released today.
For the first time, a United Nations report focuses on bodily autonomy: the power and agency to make choices about your body, without fear of violence or having someone else decide for you. This lack of bodily autonomy has massive implications beyond the profound harms to individual women and girls: potentially depressing economic productivity, undercutting skills, and resulting in extra costs to health care and judicial systems. ....

New York , United States , Eddie Wright , Natalia Kanem , United Nations , World Population , Sexual And Reproductive Health , Reproductive Rights , Human Rights And Civil Liberties , Social Affairs , Birth Control , Sex In Society , Sexual Health , Social Issues , Globe Newswire , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , எட்டி ரைட் , ஒன்றுபட்டது நாடுகள் , உலகம் பாப்யுலேஶந் , பாலியல் மற்றும் இனப்பெருக்கம் ஆரோக்கியம் , இனப்பெருக்கம் உரிமைகள் , மனிதன் உரிமைகள் மற்றும் சிவில் சுதந்திரங்கள் , சமூக வாழ்க்கைத்தொழில்கள் , பிறப்பு கட்டுப்பாடு , செக்ஸ் இல் சமூகம் ,

Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women

Press release content from Business Wire. The AP news staff was not involved in its creation.
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
March 11, 2021 GMT
SAN DIEGO (BUSINESS WIRE) Mar 11, 2021
Illumina, Inc. (NASDAQ: ILMN), along with researchers at the University of Colorado and Harvard Pilgrim Health Care (HPHC), reported study results evaluating the impact of an innovative risk-sharing agreement that opened insurance coverage of non-invasive prenatal testing (NIPT) for pregnant women under the age of 35. Through this partnership, thousands of women gained access to NIPT and the economic impact was minimal. The study showed expanding NIPT services only increased HPHC’s costs by less than 3 cents per member per month. The study was published on March 11 in the open access journal ....

United States , Karen Birmingham , R Brett Mcqueen , Juliet Cunningham , Michael Sherman , Ammar Qadan , Harvard Pilgrim Health Care , Tufts Health Plan , Exchange Commission , University Of Colorado Skaggs School Pharmacy , American College Of Obstetricians , University Of Colorado , Illumina Inc , Colorado Skaggs School , Pharmaceutical Sciences , Northeastern United States , Vice President , Global Head , Market Access , American College , Chief Medical Officer , Tufts Health , Business Wire , Sexual And Reproductive Health , Pregnancy And Childbirth , Medical Research ,

Masimo Monitoring Solutions Promote Newborn and Maternal Safety

Press release content from Business Wire. The AP news staff was not involved in its creation.
Masimo Monitoring Solutions Promote Newborn and Maternal Safety
March 8, 2021 GMT
Masimo Newborn Sensor (Photo: Masimo)
NEUCHATEL, Switzerland (BUSINESS WIRE) Mar 8, 2021
Masimo (NASDAQ: MASI) provides a variety of innovative monitoring solutions designed to improve maternal and newborn safety during childbirth and the critical first minutes of life. Masimo SET ® pulse oximetry’s ability to measure during motion and low perfusion has helped newborns, neonates, and pediatric patients like no other pulse oximetry. Not only has Masimo SET ® helped clinicians reduce retinopathy of prematurity (ROP) 1 and improve screening for critical congenital heart disease (CCHD), 2-10 but it has helped push the standard of care for babies to new heights the evidence from CCHD studies with SET ®, for example, has been used in the establishment of screening guidelines used around t ....

United States , United Kingdom , Asrat Dibaba Tolossa , Marcelo Cardetti , Katsuyuki Miyasaka , Joe Kiani , Masimo Safetynet , Masimo Rad , Mark Ansermino , Hernando Baquero , Sergio Golombek , Department Of Anesthesiology , University Of British Columbia , Child Health Program , Party For The Global Affairs Canada , International Women Day , American Society Of Neonatology , Maternity Of The Center , Nutrition Services To Improve Maternal , Us Department Of Health , Human Services , International Child Health , Screening Panel , Wayo Women University Graduate School , Exchange Commission , University Healthsystem Consortium ,

Indiana House: Doctors should be required to tell women some abortions can be 'reversed'

Doctors soon may be required by the state of Indiana to provide women seeking a pill-induced abortion with medical advice that’s not supported by any scientific study. ....

United States , Peggy Mayfield , Robin Shackleford , Senate House , Drug Administration , American Civil Liberties Union , American Congress , Republican Controlled House , Senate House Bill , Republican Controlled Senate , Planned Parenthood , Womens Health , Government Regulations , Government And Politics , State Legislature , State Governments , Emergency Contraception , Birth Control , Sexual And Reproductive Health , Healthcare Industry Regulation , Industry Regulation , Government Business And Finance , ஒன்றுபட்டது மாநிலங்களில் , பெக்கி மேஃபீல்ட் , ராபின் ஷேக்கிள்ஃபோர்ட் , செனட் வீடு ,

Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy .
Helsinn Healthcare S.A.February 18, 2021 GMT
Helsinn announces publication of latest mechlorethamine gel research, highlighting its efficacy and safety
Lugano, Switzerland, February 18, 2021 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, is pleased to note two recent journal publications on the use of mechlorethamine gel 0.016% as a topical treatment of early stage mycosis fungoides-type cutaneous T-cell lymphoma (“MF-CTCL”).
Mechlorethamine gel 0.016%, also known as chlormethine gel, is approved for use in multiple countries including the US and EU and is marketed under the trade names VALCHLOR® and LEDAGA®. The authorized use for each country varies based on the design of the registrational trial and ....

Williaml Bailey , Larisaj Geskin , Paola Bonvicini , Helsinn Investment Fund , Helsinn Therapeutics Us Inc , Swiss Pharma Company , China Helsinn Pharmaceuticals , Group Head Of Communication , Helsinn Group Media Contact , Scientific Affairs , Helsinn Group , Ireland Helsinn Birex Pharmaceuticals , Treatment Patterns , Mechlorethamine Gel , By Time Reanalysis , Randomized Controlled Phase , Clinical Lymphoma Myeloma , Systemic Absorption , Topical Mechlorethamine Gel , Mycosis Fungoides Cutaneoust Cell , Associate Professor , Columbia University Medical , Lead Author , By Time Reanalysis Manuscript , Systemic Absorption Research Letter , Helsinn Therapeutics ,